CA1067069A - Process for making an octapeptide useful for the treatment of diabetes - Google Patents

Process for making an octapeptide useful for the treatment of diabetes

Info

Publication number
CA1067069A
CA1067069A CA242,731A CA242731A CA1067069A CA 1067069 A CA1067069 A CA 1067069A CA 242731 A CA242731 A CA 242731A CA 1067069 A CA1067069 A CA 1067069A
Authority
CA
Canada
Prior art keywords
octapeptide
condensation
leu
formula
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA242,731A
Other languages
English (en)
French (fr)
Other versions
CA242731S (en
Inventor
Joseph Bornstein
Pierre Lefrancier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Choay SA
Original Assignee
Choay SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Choay SA filed Critical Choay SA
Application granted granted Critical
Publication of CA1067069A publication Critical patent/CA1067069A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA242,731A 1974-12-31 1975-12-30 Process for making an octapeptide useful for the treatment of diabetes Expired CA1067069A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7443513A FR2296427A1 (fr) 1974-12-31 1974-12-31 Agent peptidique de regulation de la glycemie

Publications (1)

Publication Number Publication Date
CA1067069A true CA1067069A (en) 1979-11-27

Family

ID=9146868

Family Applications (1)

Application Number Title Priority Date Filing Date
CA242,731A Expired CA1067069A (en) 1974-12-31 1975-12-30 Process for making an octapeptide useful for the treatment of diabetes

Country Status (13)

Country Link
US (2) US4107158A (esLanguage)
JP (1) JPS5191227A (esLanguage)
AU (1) AU8796175A (esLanguage)
BE (1) BE837250A (esLanguage)
CA (1) CA1067069A (esLanguage)
CH (1) CH605682A5 (esLanguage)
DE (1) DE2559299A1 (esLanguage)
DK (1) DK594575A (esLanguage)
ES (1) ES443969A1 (esLanguage)
FR (1) FR2296427A1 (esLanguage)
GB (1) GB1536878A (esLanguage)
NL (1) NL7514873A (esLanguage)
SE (1) SE7514714L (esLanguage)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK371079A (da) * 1978-09-28 1980-03-29 Nordisk Insulinlab Therapeutisk aktive polypeptider eller syreadditionssalte derr af og fr&mgangsmaade til fremstilling af saadanne forbindelse
US4699897A (en) * 1983-06-04 1987-10-13 Amgen Biologically active peptides structurally related to regions within growth hormones
US4558033A (en) * 1983-06-06 1985-12-10 Amgen Potentiation of the effects of insulin by peptides
US6048840A (en) * 1987-11-02 2000-04-11 Monash University Hypoglycaemic peptides
EP0386044B1 (en) * 1987-11-02 1997-01-08 Monash University Hypoglycaemic peptides
DE4331134A1 (de) * 1993-09-14 1995-03-16 Bayer Ag Neue antiviral wirksame Pseudopeptide
EP1325029A2 (en) * 2000-09-28 2003-07-09 Eli Lilly And Company Secreted proteins and their uses
MX357121B (es) * 2011-03-01 2018-06-27 Synergy Pharmaceuticals Inc Star Proceso de preparacion de agonistas c de guanilato ciclasa.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU166913B (esLanguage) * 1972-05-15 1975-06-28
US3862927A (en) * 1973-02-26 1975-01-28 Sami I Said Process for preparation of vasoactive intestinal peptide
DE2315271C3 (de) * 1973-03-27 1975-09-11 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen L- Norleucin-13-Motilin, Verfahren zu dessen Herstellung und dasselbe enthaltendes Mittel
US3928306A (en) * 1973-10-23 1975-12-23 Eisai Co Ltd Peptides having xenopsin-like pharmacological activity

Also Published As

Publication number Publication date
DK594575A (da) 1976-07-01
NL7514873A (nl) 1976-07-02
JPS5191227A (esLanguage) 1976-08-10
US4107158A (en) 1978-08-15
BE837250A (fr) 1976-06-30
ES443969A1 (es) 1977-04-16
CH605682A5 (esLanguage) 1978-10-13
FR2296427B1 (esLanguage) 1978-07-21
US4125606A (en) 1978-11-14
DE2559299A1 (de) 1976-07-08
FR2296427A1 (fr) 1976-07-30
SE7514714L (sv) 1976-07-01
AU8796175A (en) 1977-07-07
GB1536878A (en) 1978-12-20

Similar Documents

Publication Publication Date Title
CA1271298A (en) Polypeptides with an anticoagulant action, a process to prepare or obtain them, their use and agents containing them
Ondetti et al. Side reactions in the synthesis of peptides containing the aspartylglycyl sequence
US4701440A (en) Insulin derivatives, processes for their preparation and their use, and pharmaceutical agents for the treatment of diabetes mellitus
JP2633481B2 (ja) 酵素抵抗性免疫調節ペプチド
US3853837A (en) Novel nonapeptide amide analogs of luteinizing hormone releasing factor
FI60553B (fi) Foerfarande foer framstaellning av ovulationsframkallande nonapeptidamidderivat
Ondetti et al. The synthesis of secretin. III. The fragment-condensation approach
PT87350B (pt) Processo para a preparacao de peptideos com accao de inibicao de fosfolipase a2 e de composicoes farmaceuticas que os contem
US4269827A (en) Process and composition for reducing blood pressure
US4223016A (en) Peptides
US4107158A (en) Process for making an octapeptide useful for the treatment of diabetes
GB2164044A (en) A-hanp related polypeptides and their use
US3472832A (en) Peptides related to caerulein
US4280953A (en) Glycosylated analogs of somatostatin
US4560505A (en) Retro-inverso analog of the (5-14) decapeptide of equine angiotensinogen, as a specific renin inhibitor with high resistance to enzymatic hydrolysis
CA1249396A (en) Partially retro-inverted decapeptide as a specific renin inhibitor with high resistance to enzymatic hydrolysis
AU696090B2 (en) New glucocorticoids
US3862927A (en) Process for preparation of vasoactive intestinal peptide
JPH0631314B2 (ja) 新規なゴナドリベリン誘導体
US3801561A (en) Derivatives of salmon thyrocalcitonin
JPH0796557B2 (ja) 新規ペプチド、その製法およびそれを含有する医薬組成物
US4117117A (en) Tridecapetide having gastrin effect
HU191961B (en) Process for producing 1,5 and 8 substituted peptides of angiotenzin-ii antagonistic activity
Diaz et al. A large-scale synthesis of somatostatin for clinical use by a novel alternating solution/solid-phase procedure
JP2782232B2 (ja) プロテアーゼ阻害剤